, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced the launch of its Clinical Surveillance product for hospitals, which is an automated ...

Alere's Apollo technology, a fully integrated health management solution connecting providers, payers and patients, combined with Business Process Management (BPM) technology from Pegasystems, will ...

Shares of Alere (NYSE: ALR), a provider of diagnostic tests to the medical community for disease detection, plunged as much as 16% during Friday's trading session after releasing disappointing ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: Alere ...

What: Shares of Alere (NYSE: ALR), a provider of point-of-care and in-home medical diagnostic tests, surged as much as 12% during Friday's afternoon trading session. The culprit behind the move ...

Shares in Waltham, Mass.-based Alere rose after the company publically agreed to hand over documents disclosing its foreign operations and U.S. billing practices to Abbot Park, Ill.-based Abbott ...

North suburban-based Abbott Laboratories is making up with Alere after nearly a year of fighting, agreeing to buy the Massachusetts-based company for a lower price and ending its legal battles over ...